An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity
An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity is a paper indexed in PICO Portal from OpenAlex.
How many citations does An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity have?
An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity has 314 citations in the OpenAlex counts PICO Portal stores.
When was An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity published?
An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity has 2011 year in the PICO Portal index.
What is the open-access status of An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity?
An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity has green oa status in the PICO Portal index.
What is the DOI of An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity?
The DOI for An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity is on the source record.
What is the PMID of An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity?
The PMID for An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity is on the source record.
What is the OpenAlex record for An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity?
The OpenAlex for An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity is on the source record.